| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 9 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | United States | 3 | |
| #4 | Australia | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Canada | 1 | |
| #7 | New Zealand | 1 | |
| #8 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hart John Ernest | 13 |
| Publication | Filing date | Title |
|---|---|---|
| EP2234632A2 | Proteinaceous compounds | |
| GB0800502D0 | Peptides and their uses | |
| GB0800373D0 | A peptide | |
| GB0705037D0 | A Peptide | |
| GB0704866D0 | A peptide | |
| GB0605042D0 | A Peptide | |
| GB0504697D0 | A peptide | |
| GB0400484D0 | A peptide | |
| GB0326238D0 | Inhibitor-depleted media for cell and tissue culture | |
| GB0229876D0 | Peptide hormone with wide-ranging biological activities | |
| AU6406701A | Purified material having size and growth inhibitory effects on cells and tissues |